1. Home
  2. ULBI vs SCPH Comparison

ULBI vs SCPH Comparison

Compare ULBI & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ULBI
  • SCPH
  • Stock Information
  • Founded
  • ULBI 1990
  • SCPH 2013
  • Country
  • ULBI United States
  • SCPH United States
  • Employees
  • ULBI N/A
  • SCPH N/A
  • Industry
  • ULBI Industrial Machinery/Components
  • SCPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • ULBI Miscellaneous
  • SCPH Health Care
  • Exchange
  • ULBI Nasdaq
  • SCPH Nasdaq
  • Market Cap
  • ULBI 128.6M
  • SCPH 299.0M
  • IPO Year
  • ULBI 1992
  • SCPH 2017
  • Fundamental
  • Price
  • ULBI $6.84
  • SCPH $5.63
  • Analyst Decision
  • ULBI Strong Buy
  • SCPH Buy
  • Analyst Count
  • ULBI 1
  • SCPH 3
  • Target Price
  • ULBI $14.00
  • SCPH $12.00
  • AVG Volume (30 Days)
  • ULBI 56.1K
  • SCPH 2.4M
  • Earning Date
  • ULBI 11-07-2025
  • SCPH 11-12-2025
  • Dividend Yield
  • ULBI N/A
  • SCPH N/A
  • EPS Growth
  • ULBI N/A
  • SCPH N/A
  • EPS
  • ULBI 0.19
  • SCPH N/A
  • Revenue
  • ULBI $178,853,000.00
  • SCPH $49,969,000.00
  • Revenue This Year
  • ULBI $31.30
  • SCPH $104.30
  • Revenue Next Year
  • ULBI $6.24
  • SCPH $76.06
  • P/E Ratio
  • ULBI $35.23
  • SCPH N/A
  • Revenue Growth
  • ULBI 5.86
  • SCPH 107.79
  • 52 Week Low
  • ULBI $4.07
  • SCPH $1.94
  • 52 Week High
  • ULBI $10.09
  • SCPH $6.28
  • Technical
  • Relative Strength Index (RSI)
  • ULBI 45.53
  • SCPH 63.97
  • Support Level
  • ULBI $6.74
  • SCPH $4.33
  • Resistance Level
  • ULBI $7.02
  • SCPH $5.62
  • Average True Range (ATR)
  • ULBI 0.29
  • SCPH 0.04
  • MACD
  • ULBI 0.04
  • SCPH -0.01
  • Stochastic Oscillator
  • ULBI 32.93
  • SCPH 86.67

About ULBI Ultralife Corporation

Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.

Share on Social Networks: